Legion Partners Asset Management LLC 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-07 4:31 pm Purchase | 2024-10-03 | 13D | Lifecore Biomedical, Inc. LFCR | Legion Partners Asset Management LLC | 6,462,604 16.600% | 1,500,790 (+30.25%) | Filing |
| 2024-07-01 4:05 pm Purchase | 2024-06-28 | 13D | Lifecore Biomedical, Inc. LFCR | Legion Partners Asset Management LLC | 4,961,814 15.200% | 90,883 (+1.87%) | Filing |
| 2024-01-04 4:00 pm Purchase | 2023-12-24 | 13D | Lifecore Biomedical, Inc. LFCR | Legion Partners Asset Management LLC | 4,870,931 15.100% | 1,904,391 (+64.20%) | Filing |
| 2023-01-10 09:20 am Purchase | 2023-01-09 | 13D | Lifecore Biomedical, Inc. LFCR | Legion Partners Asset Management LLC | 2,966,540 9.990% | 38,450 (+1.31%) | Filing |
| 2021-08-30 5:07 pm Purchase | 2021-08-26 | 13D | Lifecore Biomedical, Inc. LFCR | Legion Partners Asset Management LLC | 2,928,090 9.940% | 23,750 (+0.82%) | Filing |
| 2020-08-24 09:15 am Purchase | 2020-08-21 | 13D | Lifecore Biomedical, Inc. LFCR | Legion Partners Asset Management LLC | 2,904,340 9.930% | 38,000 (+1.33%) | Filing |
| 2020-06-22 4:43 pm Purchase | 2020-06-18 | 13D | Lifecore Biomedical, Inc. LFCR | Legion Partners Asset Management LLC | 2,866,340 9.820% | 484,847 (+20.36%) | Filing |
| 2020-03-30 4:27 pm Purchase | 2020-03-26 | 13D | Lifecore Biomedical, Inc. LFCR | Legion Partners Asset Management LLC | 2,381,493 8.170% | 298,842 (+14.35%) | Filing |
| 2020-03-03 4:29 pm Purchase | 2020-02-28 | 13D | Lifecore Biomedical, Inc. LFCR | Legion Partners Asset Management LLC | 2,082,651 7.140% | 581,106 (+38.70%) | Filing |